CF Foundation Mission Ventures

We are investing in therapies and technologies that hold the most promise to achieve breakthroughs for everyone with CF. Working with urgency, we employ venture investment best practices to source, evaluate, and fund projects that serve the Foundation's mission. We support biotech companies through a wide range of investment vehicles and provide capital across all phases of drug development, from early-stage spinouts to mature companies pursuing late-stage trials. We also work to identify and invest in the development of platform technologies that aim to address CF’s treatment challenges. Two foundational goals drive our investments: delivering breakthrough treatments for CF manifestations and finding a transformative therapy and ultimately a cure for everyone with CF. Our portfolio supports companies pursuing genetic therapies that offer the best chance of treating the disease’s underlying cause, as well as projects aimed at relieving symptom burden for everyone with CF until a cure is found.